Stay updated on Duvelisib in Refractory Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Duvelisib in Refractory Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Duvelisib in Refractory Lymphoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision indicator on the page was updated from v3.6.6 to v3.7.0, signaling a platform update. This change affects only the version label and does not alter study information or user-facing features.
    Difference
    0.0%
    Check dated 2026-09-15T20:52:42.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.5 to v3.6.6, indicating a minor backend/content-management update to the study page.
    Difference
    0.0%
    Check dated 2026-09-01T19:49:32.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    39 days ago
    Change Detected
    Summary
    The revision label was updated from v3.6.4 to v3.6.5 to reflect a newer page version. It represents an internal metadata update and does not change the study information presented.
    Difference
    0.0%
    Check dated 2026-08-11T18:22:42.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The study page now shows revision v3.6.4, replacing the previous v3.6.3, indicating an updated version of the page content.
    Difference
    0.0%
    Check dated 2026-07-21T12:58:59.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    The page's revision indicator was updated from Revision: v3.6.0 to Revision: v3.6.3, reflecting a small platform update to the study detail page.
    Difference
    0.0%
    Check dated 2026-06-30T00:39:49.000Z thumbnail image
  8. Check
    96 days ago
    Change Detected
    Summary
    Recruitment status updated to indicate the study is no longer seeking participants. The page now includes guidance sections ('How to Read a Study Record', 'Common Questions', 'How to Join a Study') and a standardized 'Intervention/Treatment' label, alongside a revision note 'Revision: v3.6.0' and removal of the previous 'Revision: v3.5.5' version.
    Difference
    0.3%
    Check dated 2026-06-15T18:49:15.000Z thumbnail image

Stay in the know with updates to Duvelisib in Refractory Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Duvelisib in Refractory Lymphoma Clinical Trial page.